#METABOLOMICS WORKBENCH ly259_20220214_085334 DATATRACK_ID:3084 STUDY_ID:ST002084 ANALYSIS_ID:AN003401 PROJECT_ID:PR001324
VERSION             	1
CREATED_ON             	February 14, 2022, 6:27 pm
#PROJECT
PR:PROJECT_TITLE                 	Proline metabolism in T cells
PR:PROJECT_SUMMARY               	T cell metabolites detection after PRODH2-CD22-CAR knock-in.
PR:INSTITUTE                     	Yale University
PR:LAST_NAME                     	Ye
PR:FIRST_NAME                    	Lupeng
PR:ADDRESS                       	850 West campus drive
PR:EMAIL                         	lupeng.ye@yale.edu
PR:PHONE                         	2035436568
#STUDY
ST:STUDY_TITLE                   	A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline
ST:STUDY_TITLE                   	metabolism as a means to enhance CAR-T therapy
ST:STUDY_SUMMARY                 	Chimeric antigen receptor (CAR)-T cell-based immunotherapy for cancer and
ST:STUDY_SUMMARY                 	immunological diseases has made great strides, but it still faces multiple
ST:STUDY_SUMMARY                 	hurdles. Finding the right molecular targets to engineer T cells toward a
ST:STUDY_SUMMARY                 	desired function has broad implications for the armamentarium of T cell-centered
ST:STUDY_SUMMARY                 	therapies. Here, we developed a dead-guide RNA (dgRNA)-based CRISPR activation
ST:STUDY_SUMMARY                 	screen in primary CD8+ T cells, and identified gain-of-function (GOF) targets
ST:STUDY_SUMMARY                 	for CAR-T engineering. Targeted knock-in or overexpression of a lead target,
ST:STUDY_SUMMARY                 	PRODH2, enhanced CAR-T-based killing and in vivo efficacy in multiple cancer
ST:STUDY_SUMMARY                 	models. Transcriptomics and metabolomics in CAR-T cells revealed that augmenting
ST:STUDY_SUMMARY                 	PRODH2 expression re-shaped broad and distinct gene expression and metabolic
ST:STUDY_SUMMARY                 	programs. Mitochondrial, metabolic and immunological analyses showed that PRODH2
ST:STUDY_SUMMARY                 	engineering enhances the metabolic and immune functions of CAR-T cells against
ST:STUDY_SUMMARY                 	cancer. Together these findings provide a system for identification of GOF
ST:STUDY_SUMMARY                 	immune boosters, and demonstrate PRODH2 as a target to enhance CAR-T efficacy.
ST:INSTITUTE                     	Yale University
ST:LAST_NAME                     	Ye
ST:FIRST_NAME                    	Lupeng
ST:ADDRESS                       	850 West campus drive
ST:EMAIL                         	lupeng.ye@yale.edu
ST:PHONE                         	2035436568
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_Vector1 M105	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_Vector1 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_Vector2 M105	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_Vector2 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_Vector3 M105	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_Vector3 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_Vector4 M105	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_Vector4 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_Vector5 M105	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_Vector5 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_1 M105	Genotype:PRODH2-CAR | Treatment:PRODH2	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_1 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_2 M106	Genotype:PRODH2-CAR | Treatment:PRODH2	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_2 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_3 M107	Genotype:PRODH2-CAR | Treatment:PRODH2	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_3 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_4 M108	Genotype:PRODH2-CAR | Treatment:PRODH2	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_4 M105.d
SUBJECT_SAMPLE_FACTORS           	-	20190125 CarT_Prodh2_KI_5 M109	Genotype:PRODH2-CAR | Treatment:PRODH2	RAW_FILE_NAME=20190125 CarT_Prodh2_KI_5 M105.d
#COLLECTION
CO:COLLECTION_SUMMARY            	cell were counted, washed twice with PBS then used for metabolite extraction.
CO:SAMPLE_TYPE                   	T-cells
#TREATMENT
TR:TREATMENT_SUMMARY             	T cells were electroporated with Cas9-RNP, then transduced with CD22-CAR;PRODH2
TR:TREATMENT_SUMMARY             	or PRODH2(Stop) AAV, CAR-T cells were collected for metabolite extraction.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	After normalizing cell counts, 800 μL of 80 % (vol / vol) HPLC-grade methanol
SP:SAMPLEPREP_SUMMARY            	(Sigma) (precooled to -80 oC on dry ice) was added to fresh cells in a 1.5-mL
SP:SAMPLEPREP_SUMMARY            	microcentrifuge tube, then tubes were put on dry ice for 30 minutes. The tubes
SP:SAMPLEPREP_SUMMARY            	were then incubated on ice for 20 minutes and centrifuged at 15,000 x g for 15
SP:SAMPLEPREP_SUMMARY            	min at 4 oC to pellet the cell debris. The metabolite-containing supernatant was
SP:SAMPLEPREP_SUMMARY            	transferred to a new 1.5-mL microcentrifuge tube on dry ice. Metabolite
SP:SAMPLEPREP_SUMMARY            	extraction was repeated with 400 μL of 80 % (vol / vol) HPLC-grade methanol.
SP:SAMPLEPREP_SUMMARY            	The cell lysate / methanol mixtures were dried by Speedvac at room temperature.
SP:SAMPLEPREP_SUMMARY            	The metabolites were dissolved again with 80 % (vol / vol) methanol, then
SP:SAMPLEPREP_SUMMARY            	centrifuged at 18,000 x g for 10 min to remove any particulates, and the
SP:SAMPLEPREP_SUMMARY            	metabolite mixtures were stored at -80 oC until LC-MS analysis.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	HILIC
CH:INSTRUMENT_NAME               	Agilent 6490
CH:COLUMN_NAME                   	Phenomenex Kinetex C18 (150 x 2.1mm, 2.6 um)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6490 QQQ
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	Two metabolomics strategies were adopted, i.e. untargeted metabolomics (aiming
MS:MS_COMMENTS                   	to unbiasedly detect all detectable metabolites) and targeted approaches (aiming
MS:MS_COMMENTS                   	to detect specifically defined metabolites, such as related metabolites in the
MS:MS_COMMENTS                   	proline metabolism and T cell metabolism). For untargeted metabolomics analysis,
MS:MS_COMMENTS                   	the optimized workflow consists of automated peak detection and integration,
MS:MS_COMMENTS                   	peak alignment, background noise subtraction, and multivariate data analysis.
MS:MS_COMMENTS                   	These steps were carried out for comprehensive metabolite phenotyping of the two
MS:MS_COMMENTS                   	groups using Agilent Mass Hunter Qualitative Analysis Software (Version
MS:MS_COMMENTS                   	B.07.0.0, build 7.0.7024.0) and Agilent Mass Profiler Professional (Version
MS:MS_COMMENTS                   	14.5-Build 2772). The metabolites were first putatively identified based on
MS:MS_COMMENTS                   	accurate mass match (accurate mass ± 30 ppm error) and fragmentation pattern
MS:MS_COMMENTS                   	match. Putative structural annotation was carried out by searching the
MS:MS_COMMENTS                   	metabolite databases HMDB (http://www.hmdb.ca/) and METLIN (http://
MS:MS_COMMENTS                   	metlin.scripps.edu) using the mass-to-charge ratio of the metabolic features.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	ppm
MS_METABOLITE_DATA_START
Samples	20190125 CarT_Prodh2_KI_1 M105	20190125 CarT_Prodh2_KI_2 M106	20190125 CarT_Prodh2_KI_3 M107	20190125 CarT_Prodh2_KI_4 M108	20190125 CarT_Prodh2_KI_5 M109	20190125 CarT_Prodh2_KI_Vector1 M105	20190125 CarT_Prodh2_KI_Vector2 M105	20190125 CarT_Prodh2_KI_Vector3 M105	20190125 CarT_Prodh2_KI_Vector4 M105	20190125 CarT_Prodh2_KI_Vector5 M105
Factors	Genotype:PRODH2-CAR | Treatment:PRODH2	Genotype:PRODH2-CAR | Treatment:PRODH2	Genotype:PRODH2-CAR | Treatment:PRODH2	Genotype:PRODH2-CAR | Treatment:PRODH2	Genotype:PRODH2-CAR | Treatment:PRODH2	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)	Genotype:PRODH2(Stop)-CAR | Treatment:PRODH2(Stop)
4-Hydroxyproline	99747	60908	68952	52355	65804	139154	171550	172539	175270	110744
Oxoproline	41089	35687	36483	32225	42952	44431	42964	45227	28773	31479
Arginine	93427	109275	93223	66985	108574	156709	148219	119704	188062	128518
Citrulline	6427	2408	2529	3669	5456	2734	5196	7104	5501	7628
Glutamine	92860	83693	115716	128067	129830	160878	127948	127592	124887	144343
PHC	13752	20673	14267	16313	14229	8981	9030	6611	7152	7945
Proline	106041	98838	99133	103108	115949	199656	106756	153108	145377	125636
Spermine	43704	44973	58035	62606	93644	66104	82068	73033	73818	101843
Alanine	97554	82285	79439	48237	71257	112927	91452	77415	79204	85497
Argininosuccinate	825	570	595	693	774	852	727	1288	1045	1047
Asparagine	4274	3285	4039	2278	4457	6002	4522	5441	4972	6143
Cystathionine	5112	3146	4166	1692	3993	6595	2674	1981	1829	5099
Cysteine	6356	9843	10023	6033	12392	14578	12829	14408	12946	15042
Glutamate	34351	8278	49529	32363	15144	42341	13936	26117	34291	37529
Glutathione	11697	13666	16355	19829	14757	19901	13191	13409	13503	25492
Glyine	900	170	159	782	901	755	248	818	1107	709
Histidine	47429	42907	56008	71447	43208	130693	42545	60815	46591	75250
Isoleucine	9628	13182	15335	10697	11705	15807	10881	10964	21891	12417
Methionine	4703	5626	10227	11286	8314	8041	9109	7535	7914	11756
Phenylalanine	95595	96438	38118	37972	40203	69225	43412	41910	48612	52481
Threonine	682	854	371	231	375	428	525	325	298	387
Tryptophan	6042	4955	4866	4029	3943	7084	6150	5602	5851	6209
Tyrosine	7963	6665	6234	5583	10983	9551	6385	8381	7975	6309
Valine	135368	111816	281141	98582	88940	391851	338146	110874	94992	127660
2-Keto-Glutaramate	18686	13024	46146	52314	53902	43223	60647	70400	80702	82083
3-Phosphoserine	461	619	1217	672	717	659	449	305	666	1316
4-Aminobutyraldehyde	22756	22075	20435	19367	20973	21213	21148	20441	19554	20858
4-Hydroxy-Glutamate	1529	1639	2546	602	2183	735	2691	516	2055	679
6-Phosphogluconic acid	6906	17634	6599	8055	22927	9723	26437	27706	9983	17196
Aminoadipic acid	30235	12537	30865	22564	30072	51131	26583	28019	32547	25950
Inosine	3971	2313	2589	2029	2245	4442	1713	1007	1685	2041
Me-His	6213	6825	4661	5333	9098	8352	6041	7768	7977	6236
N-Acetylglutamic acid	10643	8767	8796	6101	7965	19889	12381	12027	13917	8688
Taurine	25275	15936	8448	7384	15112	35736	19505	18750	19668	22001
3-Hydroxybutyric acid	408	479	634	1436	981	1025	871	911	555	635
Acetoacetic acid	5742	4221	6363	6643	5310	7484	7302	7168	9535	7441
Fructose bisphosphate	1008	721	1004	422	770	517	1126	761	653	1786
Glucose	12841	8593	11537	10544	8784	10418	8776	16370	16259	17542
Glucose-phosphate	9406	9043	6017	9186	8852	18070	15886	14383	14509	15811
Glyceraldehyde-phosphate	18820	11370	17804	8882	8546	12053	8207	8091	14580	7696
Glyoxylate	6818	6833	8681	4712	5023	11981	7294	9409	8006	9646
Lactate	2544	2803	3245	2649	1768	3823	2440	2904	1423	2096
Phosphoenolpyruvate	8719	10241	10901	12055	11267	13556	10240	8202	8901	13880
Pyruvate	12319	15472	12579	16489	14993	18085	14570	16601	17453	17726
Dihydroxyacetone phosphate	5637	3935	1988	5263	4909	3344	3843	1444	5867	5202
Hydroxypyruvic acid	19532	13264	19757	10034	8010	9061	8339	14447	11487	8457
PRPP	3215	2863	3367	9491	4513	1296	965	1943	3604	1791
UDP-glucose	3357	4968	3238	5256	6100	1261	1159	1310	1025	1821
Xylose	1073	898	376	737	456	726	466	638	537	493
Xylulose-phosphate	166845	103481	165843	179350	104250	117565	84509	83953	70992	137146
Adenylosuccinic acid	377	594	525	303	370	295	216	308	299	320
Malate	2167	2484	1932	2411	1600	1103	3045	2055	1998	2697
Citrate-Isocitrate	8400	6892	14790	1806	6074	12679	7642	4948	2027	9861
Fumarate	4086	5828	4531	5228	6956	9212	7716	6271	7054	5747
Oxaloacetate	30698	35041	24834	18329	15707	23757	11600	11632	21934	16740
Succinate	3950	2988	4573	3971	4507	4329	4369	4521	5508	5811
Carnitine	3787	1273	2539	3226	1877	4859	3669	5549	5759	7984
Carnosine	5038	2967	3784	1941	2982	5449	2015	2888	2650	3755
Creatine	16984	13750	13720	11023	10581	16904	10323	18147	13907	12353
Creatinine	139	300	126	178	420	149	109	120	148	133
Guanine	29610	18799	21294	14949	17093	23562	8738	22431	18622	19655
NAD+	3785	6259	4249	4919	3470	272	5451	6317	2558	2393
NADH	477	1114	392	2058	899	599	580	1131	1346	644
NADP+	18388	32224	27033	27929	27321	166	31546	33112	18488	19706
NADPH	201	298	447	119	189	191	120	123	196	188
ADP	54683	47319	50504	70409	43480	27176	47055	49249	45138	51578
AMP	14643	8129	16878	17474	7511	10129	15122	13651	16165	11581
ATP	2500	2236	2416	2834	3111	2042	2174	2269	2153	2453
cAMP	509	289	421	200	203	274	193	82	126	214
GDP	11331	12321	12790	12111	10364	19010	11427	10141	12062	11425
GMP	10807	20708	20929	20987	19760	20475	24628	22921	13599	19492
GTP	626	781	1788	1152	775	544	504	667	1197	319
Acetoacetyl-CoA	599	1054	1644	1693	911	145	1173	1679	538	137
HMG-CoA	4495	1138	2722	1158	1878	2259	1468	835	246	4856
Malonyl-CoA	334	581	734	585	447	375	592	680	506	347
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name
4-Hydroxyproline
Oxoproline
Arginine
Citrulline
Glutamine
PHC
Proline
Spermine
Alanine
Argininosuccinate
Asparagine
Cystathionine
Cysteine
Glutamate
Glutathione
Glyine
Histidine
Isoleucine
Methionine
Phenylalanine
Threonine
Tryptophan
Tyrosine
Valine
2-Keto-Glutaramate
3-Phosphoserine
4-Aminobutyraldehyde
4-Hydroxy-Glutamate
6-Phosphogluconic acid
Aminoadipic acid
Inosine
Me-His
N-Acetylglutamic acid
Taurine
3-Hydroxybutyric acid
Acetoacetic acid
Fructose bisphosphate
Glucose
Glucose-phosphate
Glyceraldehyde-phosphate
Glyoxylate
Lactate
Phosphoenolpyruvate
Pyruvate
Dihydroxyacetone phosphate
Hydroxypyruvic acid
PRPP
UDP-glucose
Xylose
Xylulose-phosphate
Adenylosuccinic acid
Malate
Citrate-Isocitrate
Fumarate
Oxaloacetate
Succinate
Carnitine
Carnosine
Creatine
Creatinine
Guanine
NAD+
NADH
NADP+
NADPH
ADP
AMP
ATP
cAMP
GDP
GMP
GTP
Acetoacetyl-CoA
HMG-CoA
Malonyl-CoA
METABOLITES_END
#END